うつ病の集団認知行動療法プログラムに関するコントロール研究

抑郁症团体认知行为治疗计划的对照研究。

• 批准号: 17730415
• 负责人: 松永 美希
• 金额: $ 0.77万
• 依托单位: Kibi International University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Young Scientists (B)
• 财政年份: 2005
• 资助国家: 日本
• 起止时间: 2005 至 2006
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-17730415/
• 关键词: うつ病; 集団心理療法; 認知行動療法; 効果研究

本研究の目的は,うつ病に対する集団認知行動療法プログラムの効果を検討することである.平成18年度は,昨年度に引き続き,うっ病患者を対象に集団認知行動療法プログラムを実施し,その短期的効果を検討するとともに,コントロール群データを収集し,集団認知行動療法群との比較検討を行った.対象者は,うつ病患者18名(男性16名,女性2名.平均年齢43.6±8.5歳)であった.1名を除き,17名は薬物療法を併用した.集団認知行動療法プログラムは12セッション(約3ヶ月間)からなり,各セッションのねらいは心理教育,自己理解,思考の再検討,生活場面での実践,再発予防であった.1グループは患者4-6名で構成され,スタッフ3名でプログラムを実施した.さらにプログラム前後に,抑うつ症状(BDI, HAM-D),社会的機能(SF-36),非機能的認知(ATQ-R, DAS)を測定した.一方,コントロール群は薬物治療中のうつ病患者6名(男性2名,女性4名.平均年齢44.5±9.1歳)であった.コントロール群には,質問紙調査(BDI, SF-36,ATQ-R, DAS)を約3ヶ月の間隔をおいて2回実施した.まず集団認知行動療法群18名の抑うつ症状および心理・社会的機能について,時期を要因とした分散分析を行った.その結果,BDI, HAM-D, SF-36「身体機能」「活力」「社会生活機能」,ATQ-R「肯定的思考」について改善が認められた.次に,集団認知行動療法群とコントロール群の各指標の変化量について,群を要因とした分散分析を行った結果,いずれの指標も群の差は認められなかった.以上のことから,うっ病の集団認知行動療法プログラムと薬物療法の併用は,抑うつ症状や心理・社会的機能の改善に有効であることが確認されたが,その効果は薬物療法単独に比べて優れているとまではいえなかった.今後はさらにサンプル数を増やして検討する必要がある.

The purpose of this study is to learn about the behavior of the disease. The results show that the disease is not effective. In the year of Pingcheng 18, there was an introduction last year, and the sick patients were treated in the same way as the action group. The short-term results were analyzed, and the data of the group were collected. There were 18 patients (16 males and 2 females). The average year was 43.6 ±8.5 years. 1 was removed, and 17 were used. During the 12-month training program, each of them conducted psychological education, understood it, thought about it, and practiced it in their daily life. Then, 4-6 patients became obstetrical, and 3 received medical treatment. Check the symptoms (BDI, HAM-D), SF-36 (social function), and ATQ-R (DAS) of the society before and after treatment. On the other hand, there were 6 patients (2 males and 4 females) in the physical therapy group. The average year is 44.5 ±9.1 years. Every three months (BDI, SF-36,ATQ-R, DAS), there will be two cycles of treatment. A total of 18 people in the exercise group were aware of the psychosocial ability of the 18 patients with symptoms, and the time was due to the dispersion of the symptoms. The results show that BDI, HAM-D, SF-36 "physical ability", "vitality", "social life machine ability", and ATQ-R "definitely think" about improving health care. For the second time, it is necessary to recognize that the behavior of the group is different from that of the group, and that the group is due to the results of the dispersion analysis. The above symptoms were detected, and the action methods were used. The psychosocial mechanisms for symptom suppression were improved. The symptoms were confirmed by the physical method, which was more effective than that of the control group. In the future, I will tell you how many times I need to know.